Evidence map›Paper›PMID 40095080›Full record

ArticleArchives of dermatological research2025

The role of C4d expression in the diagnosis of bullous pemphigoid: a clinical and histopathological study.

Şeyhmus Kaya, Ramazan Oğuz Yüceer, Mustafa Tosun, Reikhan Mustafaeva

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Şeyhmus KayaFaculty of Medicine, Department of Pathology, Sivas Cumhuriyet University, Sivas, Turkey. drseyhmuskaya21@gmail.com.ORCID http://orcid.org/0000-0003-4059-9946
Ramazan Oğuz YüceerFaculty of Medicine, Department of Pathology, Sivas Cumhuriyet University, Sivas, Turkey.ORCID http://orcid.org/0000-0002-9418-8862
Mustafa TosunFaculty of Medicine, Department of Dermatology, Sivas Cumhuriyet University, Sivas, Turkey.ORCID http://orcid.org/0000-0002-6189-8016
Reikhan MustafaevaFaculty of Medicine, Department of Dermatology, Sivas Cumhuriyet University, Sivas, Turkey.ORCID http://orcid.org/0009-0001-2016-8623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory processes play a crucial role in both autoimmune and non-autoimmune skin diseases. The complement system contributes to these processes, with both well-established and yet-to-be-confirmed effects. The relationship between C4d, an intermediate product of the complement system, and skin diseases remains an area of ongoing investigation. While the presence and role of C4d in autoimmune and non-autoimmune skin diseases have been explored using immunohistochemical methods, the topic remains inconclusive. Bullous pemphigoid is an autoimmune skin disorder characterized by subepidermal blistering, predominantly affecting the elderly population. This study aims to evaluate the potential of C4d as an alternative immunohistochemical marker to the gold-standard diagnostic method, direct immunofluorescence, in diagnosing Bullous pemphigoid. Additionally, C4d staining patterns were analyzed in correlation with clinical data to assess its prognostic significance. In this retrospective study, the histomorphological, clinical, and demographic data of 43 patients diagnosed with Bullous pemphigoid were analyzed. Immunohistochemical assessment of C4d expression and staining patterns was conducted. The findings suggest that C4d may serve as a potential diagnostic and prognostic marker. C4d expression was significantly more frequent in lesions located on the upper extremities and in patients with higher eosinophil scores. Furthermore, patients with high eosinophil scores were more likely to receive systemic treatment. This study demonstrates that C4d could contribute significantly to the diagnostic process, particularly in cases where immunofluorescence studies are limited.

Indexed as

Complement C4bPemphigoid, BullousPeptide FragmentsSkinAdultAgedAged, 80 and overBiomarkersEosinophilsFemaleFluorescent Antibody Technique, DirectHumansImmunohistochemistryMaleMiddle AgedPrognosisBiomarkersComplement C4bcomplement C4dPeptide FragmentsBullous pemphigoidC4dEosinophilGliptin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.